Cancer Therapy
Q&A: A call to action to end disparities in cardio-oncology research and care
Drivers of racial and ethnic disparities in cardio-oncology include increased risk factors among historically underrepresented groups, underrepresentation in clinical trials and socioeconomic barriers, researchers reported.
Disruptive Innovators: Edward S. Kim, MD, MBA
In this episode, Edward S. Kim, MD, MBA, discusses his path to oncology, how he views disruption in health care, and the ways he’s innovating to help both patients and providers.
Chatbot offers real-time medication, symptom support for patients with cancer
Linda A. Jacobs, PhD, CRNP, FAAN, spoke at the virtual Cancer Center Survivorship Research Forum about a telehealth chatbot technology that has shown success in helping patients manage their cancer medications and symptoms at home.
Pharma exec finds switch from academia leads to rewarding connection with patients
Having participated in teams that brought five drugs to market, Uma Sinha, PhD, said one of the greatest rewards of working in the biotechnology industry is seeing how novel therapies extend and improve the quality of patients’ lives.
‘Get it out’ a common reaction for adults diagnosed with papillary thyroid cancer
Adults diagnosed with papillary thyroid cancer had strong emotional reactions similar to those diagnosed with more aggressive cancers, according to a study published in Thyroid.
Checkpoint induced arthritis severely impacts QoL for patients with cancer
Patients with immune checkpoint therapy-induced inflammatory arthritis report significant social, functional and emotional impacts, compared with cancer and other side effects, according to findings published in BMC Rheumatology.
3D echocardiography may predict right ventricular EF changes after cancer treatment
Measurements of right ventricular volume and strain from 3D echocardiography were linked to later changes in right ventricular ejection fraction, according to a study published in JACC: CardioOncology.
Chronic, late effects of cancer treatment: The consequences of a cure
Substantial improvements in cancer treatment during the past several decades are an unequivocal victory for oncology — making long-term survival a reality for many patients.
Are e-cigarettes a viable tool to help patients with cancer quit smoking?
Click here to read the Cover Story, “Smoking cessation should be ‘pillar’ of the cancer treatment protocol.”
The Rheumatologist, Cancer and the Breakthrough
Checkpoint inhibitors have changed the field of oncology, as well as our understanding of autoimmunity. This episode, hosted by Leonard H. Calabrese, DO, walks us through the history of checkpoint inhibitors — from Dr. William Coley’s use of infections in cancer to the development of PD-1 inhibitors.